Urogenital mycoplasma and its associations treatment option (clinical lecture)
The azithromycin-containing Hemomycin and its compliance are discussed in this article. The use of this drug enhances compliance in the treatment of female genital organs inflammatory diseases.
Main Author: | A L Tikhomirov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2013-06-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/view/28229 |
Similar Items
-
Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis
by: Farnaz Mohammadzadeh, et al.
Published: (2019-09-01) -
Macrolide-Resistant Mycoplasma genitalium Impairs Clinical Improvement of Male Urethritis After Empirical Treatment
by: Braam, J.F, et al.
Published: (2022) -
SIGNIFICANCE OF UROGENITAL INFECTIONS IN PATHOLOGY OF PREGNANCY AND DELIVERY IN EXPERIMENTS
by: I. M. Arshba, et al.
Published: (2014-06-01) -
Urogenital chlamydia infection in women: patient management tactics according to present-day foreign and Russian recommendations
by: A. A. Khryanin
Published: (2017-08-01) -
Clinical and epidemiological aspects of urogenital chlamidiosis of men
by: K. S. Akyshbayeva, et al.
Published: (2015-02-01)